메뉴 건너뛰기




Volumn , Issue , 2003, Pages 99-180

Chemical Modification of Macrolides

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84904235630     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/chin.200319261     Document Type: Chapter
Times cited : (17)

References (245)
  • 2
    • 0015225196 scopus 로고
    • Acid degradation of erythromycin A and erythromycin B
    • Kurath P., Jones P.H., Egan R.S., Perun T.J. Acid degradation of erythromycin A and erythromycin B. Experientia 1971, 27:362.
    • (1971) Experientia , vol.27 , pp. 362
    • Kurath, P.1    Jones, P.H.2    Egan, R.S.3    Perun, T.J.4
  • 3
    • 85184356939 scopus 로고
    • New ether oxime derivatives of erythromycin A: Preparation and antibacterial activities
    • Presented at 23rd Intersci. Conf. Antimicrob. Agents Chemother
    • Chantot J.F., Gasc J.C., Gouin D'Ambrieres S., Lutz A. New ether oxime derivatives of erythromycin A: Preparation and antibacterial activities. Abstr. No. 447 1983.
    • (1983) Abstr. No. 447
    • Chantot, J.F.1    Gasc, J.C.2    Gouin D'Ambrieres, S.3    Lutz, A.4
  • 4
    • 0009143392 scopus 로고
    • Structure modification of macrolide antibiotics
    • Springer-Verlag, Heidelberg, G. Lukacs, M. Ohno (Eds.)
    • Kirst H.A. Structure modification of macrolide antibiotics. Recent Progress in the Chemical Synthesis of Antibiotics 1990, 40-63. Springer-Verlag, Heidelberg. G. Lukacs, M. Ohno (Eds.).
    • (1990) Recent Progress in the Chemical Synthesis of Antibiotics , pp. 40-63
    • Kirst, H.A.1
  • 5
    • 0022641835 scopus 로고
    • Antibacterial activity of roxithromycin: A laboratory evaluation
    • Chantot J.-F., Bryskier A., Gasc J.-C. Antibacterial activity of roxithromycin: A laboratory evaluation. J. Antibiot. 1986, 39:660-668.
    • (1986) J. Antibiot. , vol.39 , pp. 660-668
    • Chantot, J.-F.1    Bryskier, A.2    Gasc, J.-C.3
  • 6
    • 0026021209 scopus 로고
    • New ether oxime derivatives of erythromycin A. A structure-activity relationship study
    • Gasc J.-C., D'Ambrieres S.G., Lutz A., Chantot J.F. New ether oxime derivatives of erythromycin A. A structure-activity relationship study. J. Antibiot. 1991, 44:313-330.
    • (1991) J. Antibiot. , vol.44 , pp. 313-330
    • Gasc, J.-C.1    D'Ambrieres, S.G.2    Lutz, A.3    Chantot, J.F.4
  • 7
    • 0021329213 scopus 로고
    • Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A
    • Morimoto S., Takahashi Y., Watanabe Y., Omura S. Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A. J. Antibiot. 1984, 37:187-189.
    • (1984) J. Antibiot. , vol.37 , pp. 187-189
    • Morimoto, S.1    Takahashi, Y.2    Watanabe, Y.3    Omura, S.4
  • 8
    • 0010778871 scopus 로고
    • [O-(2,5-Dioxahexyl)oxime]-9 de l'erythromycine A hydratee
    • Bachet B., Brassy C., Mornon J.P. [O-(2,5-Dioxahexyl)oxime]-9 de l'erythromycine A hydratee. Acta Cryst. C 1988, 44:112-116.
    • (1988) Acta Cryst. C , vol.44 , pp. 112-116
    • Bachet, B.1    Brassy, C.2    Mornon, J.P.3
  • 10
    • 0024271473 scopus 로고
    • In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: Comparison with trolenadomycin and erythromycin
    • Delaforge M., Sartori E., Mansuy D. In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: Comparison with trolenadomycin and erythromycin. Chem. Biol. Interact. 1988, 68:179-188.
    • (1988) Chem. Biol. Interact. , vol.68 , pp. 179-188
    • Delaforge, M.1    Sartori, E.2    Mansuy, D.3
  • 12
    • 0023508430 scopus 로고
    • Tissue distribution of roxithromycin
    • Bergogne-Berezin E. Tissue distribution of roxithromycin. J. Antimicrob. Chemother. 1987, 20(Suppl. B):S113-S120.
    • (1987) J. Antimicrob. Chemother. , vol.20 , Issue.SUPPL B
    • Bergogne-Berezin, E.1
  • 14
    • 0023724659 scopus 로고
    • Absorption, metabolism and excretion of RU 28,965 in humans
    • Koyama M., Tateno M. Absorption, metabolism and excretion of RU 28,965 in humans. Jpn. J. Chemother. 1988, 36(S-4):164-183.
    • (1988) Jpn. J. Chemother. , vol.36 , Issue.SUPPL 4 , pp. 164-183
    • Koyama, M.1    Tateno, M.2
  • 15
    • 0025233766 scopus 로고
    • Chemical modification of erythromycins. II. Synthesis and antibacterial activity of O-alkyl derivatives of erythromycin A
    • Morimoto S., Misawa Y., Adachi T., Nagate T., Watanabe Y., Omura S. Chemical modification of erythromycins. II. Synthesis and antibacterial activity of O-alkyl derivatives of erythromycin A. J. Antibiot. 1990, 43:286-294.
    • (1990) J. Antibiot. , vol.43 , pp. 286-294
    • Morimoto, S.1    Misawa, Y.2    Adachi, T.3    Nagate, T.4    Watanabe, Y.5    Omura, S.6
  • 17
    • 0025257310 scopus 로고
    • Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycin A, TE-031 (clarithromycin) and TE-032
    • Morimoto S., Nagate T., Sugita K., Ono T., Numata K., Miyachi J., Misawa Y., Yamada K., Omura S. Chemical modification of erythromycins. III. In vitro and in vivo antibacterial activities of new semisynthetic 6-O-methylerythromycin A, TE-031 (clarithromycin) and TE-032. J. Antibiot. 1990, 43:295-305.
    • (1990) J. Antibiot. , vol.43 , pp. 295-305
    • Morimoto, S.1    Nagate, T.2    Sugita, K.3    Ono, T.4    Numata, K.5    Miyachi, J.6    Misawa, Y.7    Yamada, K.8    Omura, S.9
  • 18
    • 0025290589 scopus 로고
    • Chemical modification of erythromycins. IV. Synthesis and biological properties of 6-O-methylerythromycin B
    • Morimoto S., Adachi T., Misawa Y., Nagate T., Watanabe Y., Omura S. Chemical modification of erythromycins. IV. Synthesis and biological properties of 6-O-methylerythromycin B. J. Antibiot. 1990, 43:544-549.
    • (1990) J. Antibiot. , vol.43 , pp. 544-549
    • Morimoto, S.1    Adachi, T.2    Misawa, Y.3    Nagate, T.4    Watanabe, Y.5    Omura, S.6
  • 20
    • 37049081069 scopus 로고
    • Origin of regioselectivity in the O-methylation of erythromycin as elucidated with the aid of computational conformational space search
    • Goto H., Kawashima Y., Kashimura M., Morimoto S., Osawa E. Origin of regioselectivity in the O-methylation of erythromycin as elucidated with the aid of computational conformational space search. J. Chem. Soc. Perkin Trans. II 1993, 1647-1654.
    • (1993) J. Chem. Soc. Perkin Trans. II , pp. 1647-1654
    • Goto, H.1    Kawashima, Y.2    Kashimura, M.3    Morimoto, S.4    Osawa, E.5
  • 21
    • 0023788644 scopus 로고
    • 14-Hydroxy-6-O-methyl erythromycins A, active metabolites of 6-O-methylerythromycin A in humans
    • Adachi T., Morimoto S., Kondoh H., Nagate T., Watanabe Y., Sota K. 14-Hydroxy-6-O-methyl erythromycins A, active metabolites of 6-O-methylerythromycin A in humans. J. Antibiot. 1988, 41:966-975.
    • (1988) J. Antibiot. , vol.41 , pp. 966-975
    • Adachi, T.1    Morimoto, S.2    Kondoh, H.3    Nagate, T.4    Watanabe, Y.5    Sota, K.6
  • 22
    • 0023689513 scopus 로고
    • Microbial transformation of 6-O-methylerythromycin derivatives
    • Sasaki J., Mizoue K., Morimoto S., Adachi T., Omura S. Microbial transformation of 6-O-methylerythromycin derivatives. J. Antibiot. 1988, 41:908-915.
    • (1988) J. Antibiot. , vol.41 , pp. 908-915
    • Sasaki, J.1    Mizoue, K.2    Morimoto, S.3    Adachi, T.4    Omura, S.5
  • 23
    • 0023788696 scopus 로고
    • Comparative pharmacokinetics of TE-031 and erythromycin stearate in rats and mice
    • Suwa T., Yoshida H., Fukushima K., Nagate T. Comparative pharmacokinetics of TE-031 and erythromycin stearate in rats and mice. Jpn. J. Chemother. 1988, 36(S-3):198-204.
    • (1988) Jpn. J. Chemother. , vol.36 , Issue.SUPPL 3 , pp. 198-204
    • Suwa, T.1    Yoshida, H.2    Fukushima, K.3    Nagate, T.4
  • 25
    • 0033802845 scopus 로고    scopus 로고
    • In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4
    • Rastogi N., Goh K.S., Berchel M., Bryskier A. In vitro activities of the ketolides telithromycin (HMR 3647) and HMR 3004 compared to those of clarithromycin against slowly growing mycobacteria at pHs 6.8 and 7.4. Anticrob. Agents Chemother. 2000, 44:2848-2852.
    • (2000) Anticrob. Agents Chemother. , vol.44 , pp. 2848-2852
    • Rastogi, N.1    Goh, K.S.2    Berchel, M.3    Bryskier, A.4
  • 26
    • 0023212808 scopus 로고
    • Erythromycin series. XII. Antibacterial in vitro evaluation of 10-dihydro-10-deoxo-11-azaerythromycin A: Synthesis and structure-activity relationship of its acyl derivatives
    • Djokic S., Kobrehel G., Lazarevski G. Erythromycin series. XII. Antibacterial in vitro evaluation of 10-dihydro-10-deoxo-11-azaerythromycin A: Synthesis and structure-activity relationship of its acyl derivatives. J. Antibiot. 1987, 40:1006-1015.
    • (1987) J. Antibiot. , vol.40 , pp. 1006-1015
    • Djokic, S.1    Kobrehel, G.2    Lazarevski, G.3
  • 30
    • 0029609478 scopus 로고
    • In vitro and in vivo antimicrobial activity of azithromycin a new macrolide antibiotic
    • Matsunaga T., Shimohira H., Oishi S., Ogawa M., Goto S. In vitro and in vivo antimicrobial activity of azithromycin a new macrolide antibiotic. Jpn. J. Chemother. 1995, 43(S-6):68-83.
    • (1995) Jpn. J. Chemother. , vol.43 , Issue.SUPPL 6 , pp. 68-83
    • Matsunaga, T.1    Shimohira, H.2    Oishi, S.3    Ogawa, M.4    Goto, S.5
  • 31
    • 0000591590 scopus 로고
    • Erythromycin series. Part 13. Synthesis and structure elucidation of 10-dihydro-10-deoxo-11-methyl-11-azaerythromycin A
    • Djokic S., Kobrehel G., Lopotar N., Kamenar B., Nagl A., Mrvos D. Erythromycin series. Part 13. Synthesis and structure elucidation of 10-dihydro-10-deoxo-11-methyl-11-azaerythromycin A. J. Chem. Res. (S) 1988, 152-153.
    • (1988) J. Chem. Res. (S) , pp. 152-153
    • Djokic, S.1    Kobrehel, G.2    Lopotar, N.3    Kamenar, B.4    Nagl, A.5    Mrvos, D.6
  • 33
    • 0025098815 scopus 로고
    • Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria
    • Goldman R.C., Fesik S.W., Doran C.C. Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. 1990, 34:426-431.
    • (1990) Antimicrob. Agents Chemother. , vol.34 , pp. 426-431
    • Goldman, R.C.1    Fesik, S.W.2    Doran, C.C.3
  • 35
    • 0000664225 scopus 로고
    • The reduction of oximes with teryalent titanium, a mild deoxymation procedure, and the partial synthesis of erythromycylamine
    • Timms G.H., Wildsmith E. The reduction of oximes with teryalent titanium, a mild deoxymation procedure, and the partial synthesis of erythromycylamine. Tetrahedron Lett. 1971, 195-198.
    • (1971) Tetrahedron Lett. , pp. 195-198
    • Timms, G.H.1    Wildsmith, E.2
  • 36
    • 0012292022 scopus 로고
    • The reaction of erythromycin hydrazone with nitrous acid, a new route to erythromycylamine
    • Wildsmith E. The reaction of erythromycin hydrazone with nitrous acid, a new route to erythromycylamine. Tetrahedron Lett. 1972, 29-30.
    • (1972) Tetrahedron Lett. , pp. 29-30
    • Wildsmith, E.1
  • 37
    • 0016014585 scopus 로고
    • Antibacterial activity of 9(S)-erythromycylamine-aldehyde condensation products
    • Massey E.H., Kitchell B.S., Martin L.D., Gerzon K. Antibacterial activity of 9(S)-erythromycylamine-aldehyde condensation products. J. Med. Chem. 1974, 17:105-107.
    • (1974) J. Med. Chem. , vol.17 , pp. 105-107
    • Massey, E.H.1    Kitchell, B.S.2    Martin, L.D.3    Gerzon, K.4
  • 39
    • 37049123503 scopus 로고
    • Substituent effects on the pKa values and rates of hydrolysis of arylmethylene-erythromycyclamines
    • Cockerill A.F., Ellis M.F., Rackham D.M., Wildsmith E. Substituent effects on the pKa values and rates of hydrolysis of arylmethylene-erythromycyclamines. J. Chem. Soc. Perkin Trans II 1973, 173-179.
    • (1973) J. Chem. Soc. Perkin Trans II , pp. 173-179
    • Cockerill, A.F.1    Ellis, M.F.2    Rackham, D.M.3    Wildsmith, E.4
  • 40
    • 85184360449 scopus 로고
    • Synthesis, structure, and biological activity of tetrahydro-1,3-oxazines derived from 9(S)-erythromycylamine and substituted acetaldehydes
    • Presented at 28th Intersci. Conf. Antimicrob. Agents Chemother
    • Maier R., Woitun E., Wetzel B., Lechner U. Synthesis, structure, and biological activity of tetrahydro-1,3-oxazines derived from 9(S)-erythromycylamine and substituted acetaldehydes. Abstr. No. 917 1988.
    • (1988) Abstr. No. 917
    • Maier, R.1    Woitun, E.2    Wetzel, B.3    Lechner, U.4
  • 42
    • 0028939892 scopus 로고
    • Dirithromycin: Introduction and historical development
    • Kirst H.A. Dirithromycin: Introduction and historical development. Drugs Today 1995, 31:89-97.
    • (1995) Drugs Today , vol.31 , pp. 89-97
    • Kirst, H.A.1
  • 43
    • 0025866979 scopus 로고
    • Cardiovascular and autonomic pharmacology of the macrolide antibiotic LY281389 in anesthetized beagles and in isolated smooth and cardiac muscles
    • Colbert W.E., Turk J.A., Williams P.D., Buening M.K. Cardiovascular and autonomic pharmacology of the macrolide antibiotic LY281389 in anesthetized beagles and in isolated smooth and cardiac muscles. Antimicrob. Agents Chemother. 1991, 35:1365-1369.
    • (1991) Antimicrob. Agents Chemother. , vol.35 , pp. 1365-1369
    • Colbert, W.E.1    Turk, J.A.2    Williams, P.D.3    Buening, M.K.4
  • 45
    • 0027437371 scopus 로고
    • Generation of stable synthetic equivalents of unstable α-α alkoxyacetaldehydes: An improved preparation of dirithromycin
    • McGill J.M. Generation of stable synthetic equivalents of unstable α-α alkoxyacetaldehydes: An improved preparation of dirithromycin. Synthesis 1993, 1089-1091.
    • (1993) Synthesis , pp. 1089-1091
    • McGill, J.M.1
  • 46
    • 37049078322 scopus 로고
    • NMR-spectroscopic and X-ray crystallographic studies on the structure, stereochemistry and conformation of a series of 9,11-cyclic aminals of (9S)-9-N-methylerythromycylamine
    • Davis J.S., Everett J.R., Hatton I.K., Hunt E., Tyler J.W., Zomaya I.I., Slawin A.M.Z., Williams D.J. NMR-spectroscopic and X-ray crystallographic studies on the structure, stereochemistry and conformation of a series of 9,11-cyclic aminals of (9S)-9-N-methylerythromycylamine. J. Chem. Soc. Perkin Trans. 1991, II:201-214.
    • (1991) J. Chem. Soc. Perkin Trans. , vol.II , pp. 201-214
    • Davis, J.S.1    Everett, J.R.2    Hatton, I.K.3    Hunt, E.4    Tyler, J.W.5    Zomaya, I.I.6    Slawin, A.M.Z.7    Williams, D.J.8
  • 47
    • 0006410730 scopus 로고
    • Molecular structure of 9-deoxy-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethylidene)oxy)-(9S)-erythromycin, a new erythromycin derivative
    • Luger P., Marier R. Molecular structure of 9-deoxy-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethylidene)oxy)-(9S)-erythromycin, a new erythromycin derivative. J. Cryst. Mol. Struct. 1979, 9:329-338.
    • (1979) J. Cryst. Mol. Struct. , vol.9 , pp. 329-338
    • Luger, P.1    Marier, R.2
  • 48
    • 85184374144 scopus 로고
    • Synthesis, characterization, epimerization and antimicrobial evaluation of epidirithromycin and related 9-N-11-O-oxazines of 9(S)-erythromycylamine
    • Presented at 32nd Intersci. Conf. Antimicrob. Agents Chemother
    • Kirst H.A., Greene J.M., Amos J.G. Synthesis, characterization, epimerization and antimicrobial evaluation of epidirithromycin and related 9-N-11-O-oxazines of 9(S)-erythromycylamine. Abstr. No. 1365 1992.
    • (1992) Abstr. No. 1365
    • Kirst, H.A.1    Greene, J.M.2    Amos, J.G.3
  • 49
    • 0021089506 scopus 로고
    • Transformation of 3-O-mycarosylerythronolide B, an intermediate of erythromycin biogenesis, into 3-O-mycarosyl-(8S)-8-fluoroerythronolide B using trifluoromethyl hypofluorite
    • Toscano L., Seghetti E. Transformation of 3-O-mycarosylerythronolide B, an intermediate of erythromycin biogenesis, into 3-O-mycarosyl-(8S)-8-fluoroerythronolide B using trifluoromethyl hypofluorite. Tetrahydron Lett. 1983, 24:5527-5530.
    • (1983) Tetrahydron Lett. , vol.24 , pp. 5527-5530
    • Toscano, L.1    Seghetti, E.2
  • 50
    • 0021227577 scopus 로고
    • Preparation of (8S)-8-fluoroerythronolide A and (8S)-8-fluoroerythronolide B, potential substrates for the biological synthesisi of new macrolide antibiotics
    • Toscano L., Fioriello G., Silingardi S., Inglesi M. Preparation of (8S)-8-fluoroerythronolide A and (8S)-8-fluoroerythronolide B, potential substrates for the biological synthesisi of new macrolide antibiotics. Tetrahedron. 1984, 40:2177-2181.
    • (1984) Tetrahedron. , vol.40 , pp. 2177-2181
    • Toscano, L.1    Fioriello, G.2    Silingardi, S.3    Inglesi, M.4
  • 56
    • 0029611126 scopus 로고
    • Antibacterial activity of azithromycin against fresh clinical isolates
    • Matsunaga T., Ogawa M. Antibacterial activity of azithromycin against fresh clinical isolates. Jpn. J. Chemother. 1995, 43(S-6):84-94.
    • (1995) Jpn. J. Chemother. , vol.43 , Issue.SUPPL 6 , pp. 84-94
    • Matsunaga, T.1    Ogawa, M.2
  • 58
    • 0029609478 scopus 로고
    • In vitro and in vivo antimicrobial activity of azithromycin, a new macrolide antibiotic
    • Matsunaga T., Shimohira H., Oishi S., Ogawa M., Goto S. In vitro and in vivo antimicrobial activity of azithromycin, a new macrolide antibiotic. Jpn. J. Chemother. 1995, 43:68-83.
    • (1995) Jpn. J. Chemother. , vol.43 , pp. 68-83
    • Matsunaga, T.1    Shimohira, H.2    Oishi, S.3    Ogawa, M.4    Goto, S.5
  • 59
    • 0023940406 scopus 로고
    • In vitro activities of azithromycin (CP-62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin
    • Barry A.L., Jones R.N., Thornsberry C. in vitro activities of azithromycin (CP-62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. Antimicrob. Agents Chemother. 1988, 32:752-754.
    • (1988) Antimicrob. Agents Chemother. , vol.32 , pp. 752-754
    • Barry, A.L.1    Jones, R.N.2    Thornsberry, C.3
  • 60
    • 0030007310 scopus 로고    scopus 로고
    • Newer macrolide antibiotics: Advantages and uses
    • Cunha B.A. Newer macrolide antibiotics: Advantages and uses. Adv. Therapy 1996, 13:29-37.
    • (1996) Adv. Therapy , vol.13 , pp. 29-37
    • Cunha, B.A.1
  • 61
    • 0024442066 scopus 로고
    • New directions for macrolide antibiotics: Pharmacokinetics and clinical efficacy
    • Kirst H.A., Sides G.D. New directions for macrolide antibiotics: Pharmacokinetics and clinical efficacy. Antimicrob. Agents Chemother. 1989, 33:1419-1422.
    • (1989) Antimicrob. Agents Chemother. , vol.33 , pp. 1419-1422
    • Kirst, H.A.1    Sides, G.D.2
  • 63
    • 0002143156 scopus 로고
    • Activity of macrolides against common pathogens in vitro
    • Arnette Blackwell, Paris, A.J. Bryskier, J.P. Butzler, H.C. Neu, P.M. Tulkens (Eds.)
    • Neu H.C. Activity of macrolides against common pathogens in vitro. Macrolides-Chemistry, Pharmacology, and Clinical Uses 1993, 167-182. Arnette Blackwell, Paris. A.J. Bryskier, J.P. Butzler, H.C. Neu, P.M. Tulkens (Eds.).
    • (1993) Macrolides-Chemistry, Pharmacology, and Clinical Uses , pp. 167-182
    • Neu, H.C.1
  • 65
    • 85184358591 scopus 로고
    • 6-Deoxyerythromycins. I. Producing organisms, isolation, separation and structure elucidation
    • Presented at 30th Intersci. Conf. Antimicrob. Agents Chemother
    • McAlpine J.B., Swanson S.J., Whittern D.N., Buko A.M., Weber J.M. 6-Deoxyerythromycins. I. Producing organisms, isolation, separation and structure elucidation. Abstr. No. 811 1990.
    • (1990) Abstr. No. 811
    • McAlpine, J.B.1    Swanson, S.J.2    Whittern, D.N.3    Buko, A.M.4    Weber, J.M.5
  • 66
    • 85184381128 scopus 로고
    • 6-Deoxyerythromycins. II. Comparative in vitro activity and in vivo efficacy
    • Presented at 30th Intersci. Conf. Antimicrob. Agents Chemother
    • Clement J.J., Hanson C., Shipkowitz N., Hardy D., Swanson R. 6-Deoxyerythromycins. II. Comparative in vitro activity and in vivo efficacy. Abstr. No. 811 1990.
    • (1990) Abstr. No. 811
    • Clement, J.J.1    Hanson, C.2    Shipkowitz, N.3    Hardy, D.4    Swanson, R.5
  • 67
    • 0021281873 scopus 로고
    • Regiospecific synthesis of 9-deoxyerythromycin A
    • Hauske J.R., Kostek G., Guadliana M. Regiospecific synthesis of 9-deoxyerythromycin A. J. Org. Chem. 1984, 49:712-714.
    • (1984) J. Org. Chem. , vol.49 , pp. 712-714
    • Hauske, J.R.1    Kostek, G.2    Guadliana, M.3
  • 70
    • 85184380146 scopus 로고
    • Effect of C-21 modifications on the antibacterial activity of (9R)-9-deoxo-9-dimethylamino erythromycin A
    • Presented at 31st Intersci. Conf. Antimicrob. Agents Chemother
    • Lartey P.A., Deninno S.L., Faghih R., Clement J.J., Plattner J.J. Effect of C-21 modifications on the antibacterial activity of (9R)-9-deoxo-9-dimethylamino erythromycin A. Abstr. No. 382 1991.
    • (1991) Abstr. No. 382
    • Lartey, P.A.1    Deninno, S.L.2    Faghih, R.3    Clement, J.J.4    Plattner, J.J.5
  • 72
  • 74
    • 0032478249 scopus 로고    scopus 로고
    • Synthesis and antibacterial activity of O-methyl derivatives of azalide antibiotics: I. 4 11 and 12-O-Me via direct methylation
    • Waddell S.T., Santorelli G.M., Blizzard T.A., Graham A., Occi J. Synthesis and antibacterial activity of O-methyl derivatives of azalide antibiotics: I. 4 11 and 12-O-Me via direct methylation. Bioorg. Med. Chem. Lett. 1998, 8:549-554.
    • (1998) Bioorg. Med. Chem. Lett. , vol.8 , pp. 549-554
    • Waddell, S.T.1    Santorelli, G.M.2    Blizzard, T.A.3    Graham, A.4    Occi, J.5
  • 75
    • 0032474529 scopus 로고    scopus 로고
    • Synthesis and antibacterial activity of O-methyl derivatives of azalide antibiotics: II. 6-O-Me derivatives via clarithromycin
    • Waddell S.T., Santorelli G.M., Blizzard T.A., Graham A., Occi J. Synthesis and antibacterial activity of O-methyl derivatives of azalide antibiotics: II. 6-O-Me derivatives via clarithromycin. Bioorg. Med. Chem. Lett. 1998, 8:1321-1326.
    • (1998) Bioorg. Med. Chem. Lett. , vol.8 , pp. 1321-1326
    • Waddell, S.T.1    Santorelli, G.M.2    Blizzard, T.A.3    Graham, A.4    Occi, J.5
  • 79
    • 0026733824 scopus 로고
    • New macrolide antibiotics: Synthesis of a 14-membered azalide
    • Jones A.B. New macrolide antibiotics: Synthesis of a 14-membered azalide. J. Org. Chem. 1992, 57:4361-4367.
    • (1992) J. Org. Chem. , vol.57 , pp. 4361-4367
    • Jones, A.B.1
  • 82
    • 0023901653 scopus 로고
    • Modification of macrolide antibiotics. Synthesis of 11-deoxy-11 (carboxyamino)-6-O-methylerythromycin A 11,12-(cyclic esters) via an intramolecular Michael reaction of O-carbamates with an α,β-unsaturated ketone
    • Baker W.R., Clark J.D., Stephens R.L., Kim K.H. Modification of macrolide antibiotics. Synthesis of 11-deoxy-11 (carboxyamino)-6-O-methylerythromycin A 11,12-(cyclic esters) via an intramolecular Michael reaction of O-carbamates with an α,β-unsaturated ketone. J. Org. Chem. 1988, 53:2340-2345.
    • (1988) J. Org. Chem. , vol.53 , pp. 2340-2345
    • Baker, W.R.1    Clark, J.D.2    Stephens, R.L.3    Kim, K.H.4
  • 83
    • 0024590644 scopus 로고
    • New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolidelincosamide-streptogramin B resistance
    • Fernandes P.B., Baker W.R., Freiberg L.A., Hardy D.J., McDonald E.J. New macrolides active against Streptococcus pyogenes with inducible or constitutive type of macrolidelincosamide-streptogramin B resistance. Antimicrob. Agents Chemother. 1989, 33:78-81.
    • (1989) Antimicrob. Agents Chemother. , vol.33 , pp. 78-81
    • Fernandes, P.B.1    Baker, W.R.2    Freiberg, L.A.3    Hardy, D.J.4    McDonald, E.J.5
  • 86
    • 0025327890 scopus 로고
    • Chemical modification of erythromycins. V. Synthesis and antibacterial activity of 4-O-methyl derivatives of erythromycin A 11,12-cyclic carbonate
    • Morimoto S., Misawa Y., Kondoh H., Watanabe Y., Omura S. Chemical modification of erythromycins. V. Synthesis and antibacterial activity of 4-O-methyl derivatives of erythromycin A 11,12-cyclic carbonate. J. Antibiot. 1990, 43:566-569.
    • (1990) J. Antibiot. , vol.43 , pp. 566-569
    • Morimoto, S.1    Misawa, Y.2    Kondoh, H.3    Watanabe, Y.4    Omura, S.5
  • 87
    • 85184383361 scopus 로고
    • A-63075, a potent 14-membered macrolide with minimal gastroitnestinal side-effects
    • Presented at 27th Intersci. Conf. Antimicrob. Agents Chemother
    • Freiberg L.A., Klein L., Hannick S., Nellans H.N., Fernandes P.B., Pernet A.G. A-63075, a potent 14-membered macrolide with minimal gastroitnestinal side-effects. Abstr. No. 224 1987.
    • (1987) Abstr. No. 224
    • Freiberg, L.A.1    Klein, L.2    Hannick, S.3    Nellans, H.N.4    Fernandes, P.B.5    Pernet, A.G.6
  • 88
    • 0032823597 scopus 로고    scopus 로고
    • New research in macrolides and ketolides since 1997
    • Bryskier A. New research in macrolides and ketolides since 1997. Exp. Opin. Invest. Drugs 1999, 8:1171-1194.
    • (1999) Exp. Opin. Invest. Drugs , vol.8 , pp. 1171-1194
    • Bryskier, A.1
  • 92
    • 85184373426 scopus 로고    scopus 로고
    • In vivo oral efficacy of CP-554,372, a new erythromycylamine C-4 carbamate, against macrolide resistant pneumococci and H. influenzae
    • Presented at 38th Intersci. Conf. Antimicrob. Agents Chemother.
    • Girard D., Mathieu H.W., Girard A.E., Finegan S.M., Menard C.A., Su W.G., Smith K.T., Rainville J.P. In vivo oral efficacy of CP-554,372, a new erythromycylamine C-4 carbamate, against macrolide resistant pneumococci and H. influenzae. Abstr. No. F-121 1998.
    • (1998) Abstr. No. F-121
    • Girard, D.1    Mathieu, H.W.2    Girard, A.E.3    Finegan, S.M.4    Menard, C.A.5    Su, W.G.6    Smith, K.T.7    Rainville, J.P.8
  • 94
    • 85184380842 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of CP-554,372, a new erythromycylamine C-4 carbamate, in murine pneumococcal pulmonary infections
    • Presented at 38th Intersci. Conf. Antimicrob. Agents Chemother.
    • Girard D., Mathieu H.W., Girard A.E., Menard C.A., Su W.G., Smyth K.T., Rainville J.P. Pharmacokinetics and pharmacodynamics of CP-554,372, a new erythromycylamine C-4 carbamate, in murine pneumococcal pulmonary infections. Abstr. No. F-120 1998.
    • (1998) Abstr. No. F-120
    • Girard, D.1    Mathieu, H.W.2    Girard, A.E.3    Menard, C.A.4    Su, W.G.5    Smyth, K.T.6    Rainville, J.P.7
  • 96
    • 0033017326 scopus 로고    scopus 로고
    • Structural elucidation of a novel erythromycin, 13-cyclopentyl-13-desethyl erythromycin B, from a recombinant Saccharopolyspora erythreaea strain, NRRL 2338pIG/1
    • Parsons I.C., Everett J.R., Pacey M.S., Ruddock J.C., Swanson A.G., Thompson C.M. Structural elucidation of a novel erythromycin, 13-cyclopentyl-13-desethyl erythromycin B, from a recombinant Saccharopolyspora erythreaea strain, NRRL 2338pIG/1. J. Antibiot. 1999, 52:190-192.
    • (1999) J. Antibiot. , vol.52 , pp. 190-192
    • Parsons, I.C.1    Everett, J.R.2    Pacey, M.S.3    Ruddock, J.C.4    Swanson, A.G.5    Thompson, C.M.6
  • 104
    • 85184367033 scopus 로고
    • Approaches to novel water-soluble prodrugs of erythromycin A. Synthesis of 2'-O-(N-alkylsuccinamoyl)-erythromycin derivatives incorporating anionic and cationic groups
    • Ackland M.J., Atkins P.J., Jones N.B. Approaches to novel water-soluble prodrugs of erythromycin A. Synthesis of 2'-O-(N-alkylsuccinamoyl)-erythromycin derivatives incorporating anionic and cationic groups. J. Chem. Res. (M) 1991, 1265-1278.
    • (1991) J. Chem. Res. (M) , pp. 1265-1278
    • Ackland, M.J.1    Atkins, P.J.2    Jones, N.B.3
  • 105
    • 0021674158 scopus 로고
    • Enzymatic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance
    • Barthelemy P., Autissier D., Verbaud G., Courvalin P. Enzymatic hydrolysis of erythromycin by a strain of Escherichia coli. A new mechanism of resistance. J. Antibiot. 1984, 37:1692-1696.
    • (1984) J. Antibiot. , vol.37 , pp. 1692-1696
    • Barthelemy, P.1    Autissier, D.2    Verbaud, G.3    Courvalin, P.4
  • 106
    • 0023262359 scopus 로고
    • Synthesis of ring-contracted derivatives of erythromycin
    • Kirst H.A., Wind J.A., Paschal J.W. Synthesis of ring-contracted derivatives of erythromycin. J. Org. Chem. 1987, 52:4359-4362.
    • (1987) J. Org. Chem. , vol.52 , pp. 4359-4362
    • Kirst, H.A.1    Wind, J.A.2    Paschal, J.W.3
  • 108
    • 25444499079 scopus 로고
    • 15-Membered macrolides via translactonization in 14-hydroxy-6-O-methylerythromycin A
    • Adachi T. 15-Membered macrolides via translactonization in 14-hydroxy-6-O-methylerythromycin A. J. Org. Chem. 1989, 54:3507-3510.
    • (1989) J. Org. Chem. , vol.54 , pp. 3507-3510
    • Adachi, T.1
  • 109
    • 0017684039 scopus 로고
    • Macrolide resistance in Staphylococcus aureus: Inducers of macrolide resistance
    • Allen N.E. Macrolide resistance in Staphylococcus aureus: Inducers of macrolide resistance. Antimicrob. Agents Chemother. 1977, 11:669-674.
    • (1977) Antimicrob. Agents Chemother. , vol.11 , pp. 669-674
    • Allen, N.E.1
  • 111
    • 85184373903 scopus 로고
    • Ketolides: A new distinct class of macrolide antibacterials-Synthesis and structural characteristics of RU 004
    • Presented at 35th Intersci. Conf. Antimicrob. Agents Chemother.
    • Agouridas C., Benedetti Y., Denis A., LeMartret O., Chantot J.F. Ketolides: A new distinct class of macrolide antibacterials-Synthesis and structural characteristics of RU 004. Abstr. No. F-157 1995.
    • (1995) Abstr. No. F-157
    • Agouridas, C.1    Benedetti, Y.2    Denis, A.3    LeMartret, O.4    Chantot, J.F.5
  • 117
    • 0034824275 scopus 로고    scopus 로고
    • Synthesis and antibacterial activity of the tricyclic ketolides TE-802 and its analogs
    • Kashimura M., Asaka T., Misawa Y., Matsumoto K., Morimoto S. Synthesis and antibacterial activity of the tricyclic ketolides TE-802 and its analogs. J. Antibiot. 2001, 54:664-678.
    • (2001) J. Antibiot. , vol.54 , pp. 664-678
    • Kashimura, M.1    Asaka, T.2    Misawa, Y.3    Matsumoto, K.4    Morimoto, S.5
  • 120
    • 85184370075 scopus 로고    scopus 로고
    • Tetracyclic ketolides, a new antibacterial macrolide. Synthesis and in vitro antibacterial activity
    • Presented at 37th Intersci. Conf. Antimicrob. Agents Chemother.
    • Phan L.T., Or Y.S., Chen Y., Chu D.T.W., Nilius A.M., Bui M.-H., Plattner J.J. Tetracyclic ketolides, a new antibacterial macrolide. Synthesis and in vitro antibacterial activity. Abstr. No. F-264 1997.
    • (1997) Abstr. No. F-264
    • Phan, L.T.1    Or, Y.S.2    Chen, Y.3    Chu, D.T.W.4    Nilius, A.M.5    Bui, M.-H.6    Plattner, J.J.7
  • 121
    • 85184377927 scopus 로고    scopus 로고
    • Synthesis and antibacterial activity of 2-halogeno, 2-methyl, and 2,3 enol-ether ketolides using β-keto-ester chemistry
    • Presented at 39th Intersci. Conf. Antimicrob. Agents Chemother.
    • Denis A., Agouridas C., Bonnefoy A., Bretin F., Fromentin C., Bonnet A. Synthesis and antibacterial activity of 2-halogeno, 2-methyl, and 2,3 enol-ether ketolides using β-keto-ester chemistry. Abstr. No. 2152 1999.
    • (1999) Abstr. No. 2152
    • Denis, A.1    Agouridas, C.2    Bonnefoy, A.3    Bretin, F.4    Fromentin, C.5    Bonnet, A.6
  • 122
  • 123
    • 85184356763 scopus 로고    scopus 로고
    • In vivo antibacterial activity of two ketolides HMR 3562 and HMR 3787 highly active against respiratory pathogens
    • Presented at 39th Intersci. Conf. Antimicrob. Agents Chemother.
    • Bonnefoy A., Denis A., Bretin F., Fromentin C., Agouridas C. In vivo antibacterial activity of two ketolides HMR 3562 and HMR 3787 highly active against respiratory pathogens. Abstr. No. F-2156 1999.
    • (1999) Abstr. No. F-2156
    • Bonnefoy, A.1    Denis, A.2    Bretin, F.3    Fromentin, C.4    Agouridas, C.5
  • 124
    • 0003197182 scopus 로고    scopus 로고
    • Synthesis and in vitro activity of C2-substituted C9-oxime ketolide
    • Presented at 40th Intersci. Conf. Antimicrob. Agents Chemother.
    • Kaneko T., McMillen W., Sutcliffe J., Duignan J., Petitpas J. Synthesis and in vitro activity of C2-substituted C9-oxime ketolide. Abstr. No. 1815 2000.
    • (2000) Abstr. No. 1815
    • Kaneko, T.1    McMillen, W.2    Sutcliffe, J.3    Duignan, J.4    Petitpas, J.5
  • 125
    • 85184363096 scopus 로고    scopus 로고
    • In vitro antibacterial activity of CP-654,743, a new C2-fluoro ketolide, against macrolide-resistant pneumococci and Haemophilus influenzae
    • Presented at 40th Intersci. Conf. Antimicrob. Agents Chemother
    • Girard D., Mathieu H.W., Finegan S.M., Cimochowski C.R., Kaneko T., McMillen W. In vitro antibacterial activity of CP-654,743, a new C2-fluoro ketolide, against macrolide-resistant pneumococci and Haemophilus influenzae. Abstr. No. F-1816. 2000.
    • (2000) Abstr. No. F-1816.
    • Girard, D.1    Mathieu, H.W.2    Finegan, S.M.3    Cimochowski, C.R.4    Kaneko, T.5    McMillen, W.6
  • 127
    • 0032892037 scopus 로고    scopus 로고
    • In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria
    • Malathum K., Coque T.M., Singh K.V., Murray B.E. In vitro activities of two ketolides, HMR 3647 and HMR 3004, against gram-positive bacteria. Antimicrob. Agents Chemother. 1999, 43:930-936.
    • (1999) Antimicrob. Agents Chemother. , vol.43 , pp. 930-936
    • Malathum, K.1    Coque, T.M.2    Singh, K.V.3    Murray, B.E.4
  • 128
    • 85184385222 scopus 로고    scopus 로고
    • Antipneumococcal activity (MIC) of HMR 3647 (RU 66647), a new ketolide, compared to 16 other agents
    • Presented at 37th Intersci. Conf. Antimicrob. Agents Chemother
    • Pankuch G.A., Jacobs M.R., Applebaum P.C. Antipneumococcal activity (MIC) of HMR 3647 (RU 66647), a new ketolide, compared to 16 other agents. Abstr. No. F-108 1997.
    • (1997) Abstr. No. F-108
    • Pankuch, G.A.1    Jacobs, M.R.2    Applebaum, P.C.3
  • 129
    • 85184382128 scopus 로고    scopus 로고
    • Activity of telithromycin (HMR 3647), a new ketolide antimicrobial, against human mycoplasma
    • Presented at 5th ICMAS-KO
    • Bebear C.M., Renaudin H., Bryskier A., Bebear C. Activity of telithromycin (HMR 3647), a new ketolide antimicrobial, against human mycoplasma. Poster No. 02.35. 2000.
    • (2000) Poster No. 02.35.
    • Bebear, C.M.1    Renaudin, H.2    Bryskier, A.3    Bebear, C.4
  • 130
    • 0031860252 scopus 로고    scopus 로고
    • In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae
    • Roblin P.M., Hammerschlag M.R. In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 1998, 42:1515-1516.
    • (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 1515-1516
    • Roblin, P.M.1    Hammerschlag, M.R.2
  • 131
    • 85184381363 scopus 로고    scopus 로고
    • B resistance induction by the ketolide telithromycin (HMR 3647): Role of the 3-keto group
    • Presented at 5th ICMAS-KO
    • B resistance induction by the ketolide telithromycin (HMR 3647): Role of the 3-keto group. Poster No. 02.10. 2000.
    • (2000) Poster No. 02.10.
    • Mauvaris, P.1    Bonnefoy, A.2
  • 132
    • 85184373330 scopus 로고    scopus 로고
    • The C 11,12-carbamate side chain of the ketolide antimicrobial telithromycin (HMR 3647) enhances binding to both MLS-sensitive and-resistant ribosome
    • Presented at 5th ICMAS-KO
    • Douthwaite S., Mauvaris P., Haastrup Hansen L. The C 11,12-carbamate side chain of the ketolide antimicrobial telithromycin (HMR 3647) enhances binding to both MLS-sensitive and-resistant ribosome. Poster No. 02.01. 2000.
    • (2000) Poster No. 02.01.
    • Douthwaite, S.1    Mauvaris, P.2    Haastrup Hansen, L.3
  • 133
    • 85184363224 scopus 로고    scopus 로고
    • Interaction of macrolides and ketolides with the ribosome
    • Presented at 5th ICMAS-KO
    • Mankin A., Xiong L., Khaitovich P. Interaction of macrolides and ketolides with the ribosome. Poster No. 01.02. 2000.
    • (2000) Poster No. 01.02.
    • Mankin, A.1    Xiong, L.2    Khaitovich, P.3
  • 134
    • 85184356693 scopus 로고    scopus 로고
    • Structure-activity relationship of the, ketolide telithromycin (HMR 3647)
    • Presented at 5th ICMAS-KO
    • Douthwaite S., Mauvaris P., Champney S., Bryskier A. Structure-activity relationship of the, ketolide telithromycin (HMR 3647). Poster No. 02.02. 2000.
    • (2000) Poster No. 02.02.
    • Douthwaite, S.1    Mauvaris, P.2    Champney, S.3    Bryskier, A.4
  • 135
    • 85184383327 scopus 로고    scopus 로고
    • Pharmacokinetics of 800 mg once-daily oral dosing of the ketolide antibacterial telithromycin (HMR 3647) in healthy young subjects
    • Presented at 5th ICMAS-KO
    • Lenfant B., Sultan E., Wable C., Pascual M.H., Meyer B.H. Pharmacokinetics of 800 mg once-daily oral dosing of the ketolide antibacterial telithromycin (HMR 3647) in healthy young subjects. Poster No. 09.21. 2000.
    • (2000) Poster No. 09.21.
    • Lenfant, B.1    Sultan, E.2    Wable, C.3    Pascual, M.H.4    Meyer, B.H.5
  • 137
    • 85184370931 scopus 로고    scopus 로고
    • Design, synthesis, and characterization of ABT-773: A novel ketolide highly active against multidrug-resistant pathogens
    • Presented at 39th Intersci. Conf. Antimicrob. Agents Chemother
    • Ma Z., Clark R.F., Or Y. Design, synthesis, and characterization of ABT-773: A novel ketolide highly active against multidrug-resistant pathogens. Abstr. No. 2133 1999.
    • (1999) Abstr. No. 2133
    • Ma, Z.1    Clark, R.F.2    Or, Y.3
  • 141
    • 85184385738 scopus 로고    scopus 로고
    • In vitro activity of ABT-773, a new ketolide antibiotic, against Chlamydia pneumoniae
    • Presented at 5th ICMAS-KO
    • Strigl S., Roblin P.M., Reznik T., Hammerschlag M.R. In vitro activity of ABT-773, a new ketolide antibiotic, against Chlamydia pneumoniae. Poster No. 02.32. 2000.
    • (2000) Poster No. 02.32.
    • Strigl, S.1    Roblin, P.M.2    Reznik, T.3    Hammerschlag, M.R.4
  • 142
    • 85184376570 scopus 로고    scopus 로고
    • Intracellular activity and post-antibiotic effect of ABT-773 against Legionella
    • Presented at 5th ICMAS-KO
    • Dubois J., St.Pierre C. Intracellular activity and post-antibiotic effect of ABT-773 against Legionella. Poster No. 02.33. 2000.
    • (2000) Poster No. 02.33.
    • Dubois, J.1    PierreSt, C.2
  • 143
    • 85184359702 scopus 로고    scopus 로고
    • Activity of ABT-773 against Mycobacterium avium complex in the Beige mouse model
    • Presented at 5th ICMAS-KO
    • Cynamon M.H., Carter J.L., Shoen C.M. Activity of ABT-773 against Mycobacterium avium complex in the Beige mouse model. Poster No. 03.14. 2000.
    • (2000) Poster No. 03.14.
    • Cynamon, M.H.1    Carter, J.L.2    Shoen, C.M.3
  • 144
    • 85184363979 scopus 로고    scopus 로고
    • The ketolide ABT-773 protects against lethal Toxoplasma gondii
    • Presented at 5th ICMAS-KO
    • Khan A.A., Araujo F.G., Craft J.C. The ketolide ABT-773 protects against lethal Toxoplasma gondii. Poster No. 03.07. 2000.
    • (2000) Poster No. 03.07.
    • Khan, A.A.1    Araujo, F.G.2    Craft, J.C.3
  • 145
    • 85184374934 scopus 로고    scopus 로고
    • Pharmacokinetics of ABT-773 in mouse, rat, monkey and dog
    • Presented at 5th ICMAS-KO
    • Hernandez L., Krill S., Ma Z., Marsh K. Pharmacokinetics of ABT-773 in mouse, rat, monkey and dog. Poster No. 09.33. 2000.
    • (2000) Poster No. 09.33.
    • Hernandez, L.1    Krill, S.2    Ma, Z.3    Marsh, K.4
  • 146
    • 0033978875 scopus 로고    scopus 로고
    • In vitro activity of ABT-773, a new ketolide, against recent clinical isolaters of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    • Brueggemann A.B., Doern G.V., Huynh H.K., Wingert E.M., Rhomberg P.R. In vitro activity of ABT-773, a new ketolide, against recent clinical isolaters of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob. Agents Chemother. 2000, 44:447-449.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 447-449
    • Brueggemann, A.B.1    Doern, G.V.2    Huynh, H.K.3    Wingert, E.M.4    Rhomberg, P.R.5
  • 148
    • 0034062940 scopus 로고    scopus 로고
    • In vitro activity of ABT-773, a new ketolide antibiotic, against Chlamydia pneumoniae
    • Strigl S., Robin P.M., Renznik T., Hammerschlag M.R. In vitro activity of ABT-773, a new ketolide antibiotic, against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 2000, 44:1112-1113.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 1112-1113
    • Strigl, S.1    Robin, P.M.2    Renznik, T.3    Hammerschlag, M.R.4
  • 149
    • 0344889213 scopus 로고    scopus 로고
    • In vitro activities of ketolide HMR 3647 and HMR 3004, Levofloxacin, and other quinolones and macrolides against, Neisseria spp. and Moraxella catarrhalis
    • Saez-Nieto J.A., Vazquez J.A. In vitro activities of ketolide HMR 3647 and HMR 3004, Levofloxacin, and other quinolones and macrolides against, Neisseria spp. and Moraxella catarrhalis. Antimicrob. Agents Chemother. 1999, 43:983-984.
    • (1999) Antimicrob. Agents Chemother. , vol.43 , pp. 983-984
    • Saez-Nieto, J.A.1    Vazquez, J.A.2
  • 150
    • 0033802846 scopus 로고    scopus 로고
    • Activity of ABT-773 against Mycobacterium avium complex in the Beige mouse model
    • Cynamon M.H., Carter J.L., Shoen C.M. Activity of ABT-773 against Mycobacterium avium complex in the Beige mouse model. Antimicrob. Agents Chemother. 2000, 44:2895-2896.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 2895-2896
    • Cynamon, M.H.1    Carter, J.L.2    Shoen, C.M.3
  • 151
    • 0033797970 scopus 로고    scopus 로고
    • Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice
    • Consigny S., Bentoucha A., Bonnafous P., Grosset J., Ji B. Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice. Antimicrob. Agents Chemother. 2000, 44:2919-2921.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 2919-2921
    • Consigny, S.1    Bentoucha, A.2    Bonnafous, P.3    Grosset, J.4    Ji, B.5
  • 152
    • 0010977811 scopus 로고    scopus 로고
    • New perspectives on macrolide antibiotics
    • Pechere J. New perspectives on macrolide antibiotics. Int. J. Antimicrob. Agents 2001, 18(Suppl. 1):93-97.
    • (2001) Int. J. Antimicrob. Agents , vol.18 , Issue.SUPPL 1 , pp. 93-97
    • Pechere, J.1
  • 153
    • 0034007778 scopus 로고    scopus 로고
    • In vitro activities of telithromycin (HMR3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis
    • Rolain J.-M., Maurin M., Bryskier A., Raoult D. In vitro activities of telithromycin (HMR3647) against Rickettsia rickettsii, Rickettsia conorii, Rickettsia africae, Rickettsia typhi, Rickettsia prowazekii, Coxiella burnetii, Bartonella henselae, Bartonella quintana, Bartonella bacilliformis, and Ehrlichia chaffeensis. Antimicrob. Agents Chemother. 2000, 44:1391-1393.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 1391-1393
    • Rolain, J.-M.1    Maurin, M.2    Bryskier, A.3    Raoult, D.4
  • 154
    • 85184382652 scopus 로고    scopus 로고
    • Telithromycin (HMR 3647) achieves high and sustained concentrations in white blood cells in man
    • Presented at 5th ICMAS-KO
    • Gia H.P., Roeder V., Namour F., Sultan E., Lenfant B. Telithromycin (HMR 3647) achieves high and sustained concentrations in white blood cells in man. Poster No. 09.27 2000.
    • (2000) Poster No. 09.27
    • Gia, H.P.1    Roeder, V.2    Namour, F.3    Sultan, E.4    Lenfant, B.5
  • 155
    • 0028302612 scopus 로고
    • Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes
    • Goldman R.C., Zakula D., Flamm R., Beyer J., Capobianco J. Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrob. Agents Chemother. 1994, 38:1496-1500.
    • (1994) Antimicrob. Agents Chemother. , vol.38 , pp. 1496-1500
    • Goldman, R.C.1    Zakula, D.2    Flamm, R.3    Beyer, J.4    Capobianco, J.5
  • 156
    • 0025098815 scopus 로고
    • Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria
    • Goldman R.C., Feski S.W., Doran C. Role of protonated and neutral forms of macrolides in binding to ribosomes from gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. 1990, 34:426-431.
    • (1990) Antimicrob. Agents Chemother. , vol.34 , pp. 426-431
    • Goldman, R.C.1    Feski, S.W.2    Doran, C.3
  • 158
    • 85184380560 scopus 로고    scopus 로고
    • Rapid drug accumulation of ABT-773 in Streptococcus pneumoniae
    • Presented at 39th Intersci. Conf. Antimicrob. Agents Chemother
    • Capobianco J.O., Shortridge V., Ma Z., Phan L., Or Y., Zhong P. Rapid drug accumulation of ABT-773 in Streptococcus pneumoniae. Abstr. No. 2137 1999.
    • (1999) Abstr. No. 2137
    • Capobianco, J.O.1    Shortridge, V.2    Ma, Z.3    Phan, L.4    Or, Y.5    Zhong, P.6
  • 160
    • 0034129333 scopus 로고    scopus 로고
    • Evermicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells
    • Champney W.S., Tober C.L. Evermicin (SCH27899) inhibits both translation and 50S ribosomal subunit formation in Staphylococcus aureus cells. Antimicrob. Agents Chemother. 2000, 44:1413-1417.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 1413-1417
    • Champney, W.S.1    Tober, C.L.2
  • 161
    • 0343362694 scopus 로고    scopus 로고
    • Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice
    • Bin X.X., Wolf K., Schaffner T., Malinverni R. Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice. Antimicrob. Agents Chemother. 2000, 44:1761-1764.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 1761-1764
    • Bin, X.X.1    Wolf, K.2    Schaffner, T.3    Malinverni, R.4
  • 162
    • 85184379265 scopus 로고    scopus 로고
    • In vitro activity of ABT-773, a new ketolide antibiotic, alone and in combination with metronidazole, amoxicillin, or tetracycline against Helicobacter pylori
    • Presented at 39th Intesci. Conf. Antimicrob. Agents Chemother.
    • Pendland S.L., Prause J.L., Neuhauser M.M., Boyea N., Hackleman J.M., Danziger L.H. In vitro activity of ABT-773, a new ketolide antibiotic, alone and in combination with metronidazole, amoxicillin, or tetracycline against Helicobacter pylori. Abstr. No. F-2145. 1999.
    • (1999) Abstr. No. F-2145.
    • Pendland, S.L.1    Prause, J.L.2    Neuhauser, M.M.3    Boyea, N.4    Hackleman, J.M.5    Danziger, L.H.6
  • 163
    • 0033914680 scopus 로고    scopus 로고
    • Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage
    • Tait-Kamrard A., Davies T., Cronan M., Jacobs M.R., Applebaum P.C., Sutcliffe J. Mutations in 23S rRNA and ribosomal protein L4 account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 2000, 44:2118-2125.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 2118-2125
    • Tait-Kamrard, A.1    Davies, T.2    Cronan, M.3    Jacobs, M.R.4    Applebaum, P.C.5    Sutcliffe, J.6
  • 164
    • 0033999158 scopus 로고    scopus 로고
    • Postantibiotic effects and bactericidal activities of clarithromycin-14-hydroxyl-clarithromycin, versus those of amoxicillin-clavulanate, against anaerobes
    • Jung R., Messick C.R., Pendland S.L., Tesoro E.P., Losendahl K.J., Schriever C.A., Danziger L.H. Postantibiotic effects and bactericidal activities of clarithromycin-14-hydroxyl-clarithromycin, versus those of amoxicillin-clavulanate, against anaerobes. Antimicrob. Agents Chemother. 2000, 44:778-779.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 778-779
    • Jung, R.1    Messick, C.R.2    Pendland, S.L.3    Tesoro, E.P.4    Losendahl, K.J.5    Schriever, C.A.6    Danziger, L.H.7
  • 166
    • 85184357068 scopus 로고    scopus 로고
    • In vitro bactericidal activity of ABT-773, a new ketolide, versus clarithromycin (CL) and azithromycin (AZ) against penicillin/erythromycin-sensitive and-resistant Streptococcus pneumoniae (SP)
    • Presented at 39th Intersci. Conf. Antimicrob. Agents Chemother.
    • Neuhauser M.M., Prause J.L., Jung R., Boyea N., Hackleman J.M., Danziger L.H., Pendland S.L. In vitro bactericidal activity of ABT-773, a new ketolide, versus clarithromycin (CL) and azithromycin (AZ) against penicillin/erythromycin-sensitive and-resistant Streptococcus pneumoniae (SP). Abstr. No. 2139 1999.
    • (1999) Abstr. No. 2139
    • Neuhauser, M.M.1    Prause, J.L.2    Jung, R.3    Boyea, N.4    Hackleman, J.M.5    Danziger, L.H.6    Pendland, S.L.7
  • 167
    • 0034117631 scopus 로고    scopus 로고
    • Postantibiotic suppression of growth of erythromycin A-susceptible and- resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004
    • Munckhof W.J., Borlace G., Turnidge J.D. Postantibiotic suppression of growth of erythromycin A-susceptible and- resistant gram-positive bacteria by the ketolides telithromycin (HMR 3647) and HMR 3004. Antimicrob. Agents Chemother. 2000, 44:1749-1753.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 1749-1753
    • Munckhof, W.J.1    Borlace, G.2    Turnidge, J.D.3
  • 168
    • 0033936568 scopus 로고    scopus 로고
    • In vitro pharmacodynamics of the new ketolides HMR 3004 and HMR 3647 (telithromycin) against Chlamydia pneumoniae
    • Gustafsson I., Hjelm E., Cars O. In vitro pharmacodynamics of the new ketolides HMR 3004 and HMR 3647 (telithromycin) against Chlamydia pneumoniae. Antimicrob. Agents Chemother. 2000, 44:1846-1849.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 1846-1849
    • Gustafsson, I.1    Hjelm, E.2    Cars, O.3
  • 170
    • 85184362786 scopus 로고    scopus 로고
    • Molecular basis of ABT-773 active against erm-containing macrolide-resistant S. pneumoniae
    • Presented at 39th Intersci. Conf. Antimicrob. Agents Chemother.
    • Zhong P., Hammond R., Cao Z., Chen Y., Shortridge A., Nilius A., Flamm R.K., Or Y. Molecular basis of ABT-773 active against erm-containing macrolide-resistant S. pneumoniae. Abstr. No. 2134 1999.
    • (1999) Abstr. No. 2134
    • Zhong, P.1    Hammond, R.2    Cao, Z.3    Chen, Y.4    Shortridge, A.5    Nilius, A.6    Flamm, R.K.7    Or, Y.8
  • 171
    • 85184374475 scopus 로고    scopus 로고
    • Antibiotics and ribosomes: Interaction of macrolide with ribosome and resistance
    • Presented at 40th Intersci. Conf. Antimicrob. Agents Chemother.
    • Mankin A. Antibiotics and ribosomes: Interaction of macrolide with ribosome and resistance. Abstr. No. G-1132. 2000.
    • (2000) Abstr. No. G-1132.
    • Mankin, A.1
  • 173
    • 85184368728 scopus 로고    scopus 로고
    • Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumoniae isolates
    • Presented at 5th ICMAS-KO
    • Jung R., Li D.H., Pendland S.L. Intracellular activity of ABT-773 and other antimicrobial agents against Legionella pneumoniae isolates. Poster No. 02.34. 2000.
    • (2000) Poster No. 02.34.
    • Jung, R.1    Li, D.H.2    Pendland, S.L.3
  • 174
    • 85184373017 scopus 로고    scopus 로고
    • Uptake of two new fluoroketolides, HMR 3562 and HMR 3787, by human neutrophils (PMN) in vitro
    • Presented at 40th Intersci. Conf. Antimicrob. Agents Chemother
    • Labro M.T., Vazifeh D., Bryskier A. Uptake of two new fluoroketolides, HMR 3562 and HMR 3787, by human neutrophils (PMN) in vitro. Abstr. No. F-1819 2000.
    • (2000) Abstr. No. F-1819
    • Labro, M.T.1    Vazifeh, D.2    Bryskier, A.3
  • 175
    • 85184367848 scopus 로고    scopus 로고
    • The ketolide antimicrobial, telithromycin (HMR 3647), achieves high and sustained concentration in alveolar macrophages and bronchoalveolar epitherial lining fluid in healthy Japanese volunteers
    • Presented at 40th Intersci. Conf. Antimicrob. Agents Chemother
    • Kadota J., Ishimatsu Y., Iwashita T., Matsubara Y., Kohno S., Tateno M., Ishihara R. The ketolide antimicrobial, telithromycin (HMR 3647), achieves high and sustained concentration in alveolar macrophages and bronchoalveolar epitherial lining fluid in healthy Japanese volunteers. Abstr. No. 2143 2000.
    • (2000) Abstr. No. 2143
    • Kadota, J.1    Ishimatsu, Y.2    Iwashita, T.3    Matsubara, Y.4    Kohno, S.5    Tateno, M.6    Ishihara, R.7
  • 177
    • 0033996304 scopus 로고    scopus 로고
    • Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils
    • Vazifeh D., Bryskier A., Labro M.T. Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils. Antimicrob. Agents Chemother. 2000, 44:511-521.
    • (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 511-521
    • Vazifeh, D.1    Bryskier, A.2    Labro, M.T.3
  • 178
    • 0035139643 scopus 로고    scopus 로고
    • Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro
    • Sato E., Nelson D.K., Koyama S., Hoyt J., Robbins R.A. Erythromycin modulates eosinophil chemotactic cytokine production by human lung fibroblasts in vitro. Antimicrob. Agents Chemother 2000, 44:401-406.
    • (2000) Antimicrob. Agents Chemother , vol.44 , pp. 401-406
    • Sato, E.1    Nelson, D.K.2    Koyama, S.3    Hoyt, J.4    Robbins, R.A.5
  • 179
    • 85184367228 scopus 로고    scopus 로고
    • Effect of ABT-773 and other antimicrobial agents on the morphology and the release of interleukin-1β and interleukin-8 against Haemophilus influenzae and Streptococcus pneumoniae in whole blood
    • Presented at 5th ICMAS-KO
    • Jung R., Bearden D.T., Danziger L.H. Effect of ABT-773 and other antimicrobial agents on the morphology and the release of interleukin-1β and interleukin-8 against Haemophilus influenzae and Streptococcus pneumoniae in whole blood. Poster No. 02.25. 2000.
    • (2000) Poster No. 02.25.
    • Jung, R.1    Bearden, D.T.2    Danziger, L.H.3
  • 180
    • 85184383217 scopus 로고    scopus 로고
    • Oral telithromycin (HMR 3647; 800mg od) for 5 days is well tolerated and as effective as cefuroxime axetil (500 mg bid) for 10 days in adults with acute exacerbations of chronic bronchitis (AECB)
    • Presented at 40th Intersci. Conf. Antimicrob. Agents Chemother
    • Deabate C.A., Heyder A., Leroy B., Sidadous E., Backstrom J. Oral telithromycin (HMR 3647; 800mg od) for 5 days is well tolerated and as effective as cefuroxime axetil (500 mg bid) for 10 days in adults with acute exacerbations of chronic bronchitis (AECB). Abstr. No. L-2228. 2000.
    • (2000) Abstr. No. L-2228.
    • Deabate, C.A.1    Heyder, A.2    Leroy, B.3    Sidadous, E.4    Backstrom, J.5
  • 181
    • 85184385143 scopus 로고    scopus 로고
    • Cytochrome P-450 (CYP-450) activity is not inhibited in vitro by telithromycin (HMR 3647), a new ketolide
    • Presented at 5th ICMAS-KO
    • Labbe G., Flor M., Lenfant B. Cytochrome P-450 (CYP-450) activity is not inhibited in vitro by telithromycin (HMR 3647), a new ketolide. Poster No. 09.28. 2000.
    • (2000) Poster No. 09.28.
    • Labbe, G.1    Flor, M.2    Lenfant, B.3
  • 182
    • 0000992991 scopus 로고
    • Antibiotics (macrolides)
    • John Wiley & Sons, Inc., New York
    • Kirst H.A. Antibiotics (macrolides). Kirt-Othmer Encyclopedia of Chemical Technology 1992, Vol. 3:169-213. John Wiley & Sons, Inc., New York. 4th Ed.
    • (1992) Kirt-Othmer Encyclopedia of Chemical Technology , vol.3 , pp. 169-213
    • Kirst, H.A.1
  • 183
    • 0003622435 scopus 로고
    • Arnette Blackwell, Paris, A.J. Bryskier, J.P. Butzler, H.C. Neu, P.M. Tulkens (Eds.)
    • Macrolides: Chemistry, Pharmacology and Clinical Uses 1993, Arnette Blackwell, Paris. A.J. Bryskier, J.P. Butzler, H.C. Neu, P.M. Tulkens (Eds.).
    • (1993) Macrolides: Chemistry, Pharmacology and Clinical Uses
  • 184
    • 0031984970 scopus 로고    scopus 로고
    • Recent developments with macrolide antibiotics
    • Kirst H.A. Recent developments with macrolide antibiotics. Exp. Opin. Ther. Patients 1998, 8:111-120.
    • (1998) Exp. Opin. Ther. Patients , vol.8 , pp. 111-120
    • Kirst, H.A.1
  • 185
    • 0032982254 scopus 로고    scopus 로고
    • Mechanisms of bacterial resistance to macrolide antibiotics
    • Nakajima Y. Mechanisms of bacterial resistance to macrolide antibiotics. J. Infect. Chemother. 1999, 5:61-74.
    • (1999) J. Infect. Chemother. , vol.5 , pp. 61-74
    • Nakajima, Y.1
  • 187
    • 0034055380 scopus 로고    scopus 로고
    • Up-to-date report on the resistance of macrolide antibiotics and future macrolides
    • O'hara K. Up-to-date report on the resistance of macrolide antibiotics and future macrolides. Jpn. J. Chemother. 2000, 48:169-190.
    • (2000) Jpn. J. Chemother. , vol.48 , pp. 169-190
    • O'hara, K.1
  • 188
    • 0001854117 scopus 로고    scopus 로고
    • Ketolide: Novel antibacterial agent designed to overcome erythromycin A resistance
    • Marcel Dekker, New York, S.H. Zinner, L.S. Young, J.F. Acar, C. Ortiz-Neu (Eds.)
    • Bryskier A., Agouridas C., Chantot J.F. Ketolide: Novel antibacterial agent designed to overcome erythromycin A resistance. New Considerations for Macrolides Azalides, Streptogramins, and Ketolides 2000, 79-102. Marcel Dekker, New York. S.H. Zinner, L.S. Young, J.F. Acar, C. Ortiz-Neu (Eds.).
    • (2000) New Considerations for Macrolides Azalides, Streptogramins, and Ketolides , pp. 79-102
    • Bryskier, A.1    Agouridas, C.2    Chantot, J.F.3
  • 190
    • 0017164832 scopus 로고
    • Modification of a macrolide antibiotic midecamycin (SF837). I. Synthesis and structure of 9,3-diacetyl midecamycin
    • Omoto S., Iwamatsu K., Inoue S., Niida T. Modification of a macrolide antibiotic midecamycin (SF837). I. Synthesis and structure of 9,3-diacetyl midecamycin. J. Antibiot. 1976, 39:536-548.
    • (1976) J. Antibiot. , vol.39 , pp. 536-548
    • Omoto, S.1    Iwamatsu, K.2    Inoue, S.3    Niida, T.4
  • 191
    • 0019824634 scopus 로고
    • In vitro and in vivo antibacterial activity of 9,3-di-O-acetyl midecamycin (MOM), a new macrolide antibiotic
    • Kawaharajo K., Sekizawa Y., Inoue M. In vitro and in vivo antibacterial activity of 9,3-di-O-acetyl midecamycin (MOM), a new macrolide antibiotic. J. Antibiot. 1981, 34:436-442.
    • (1981) J. Antibiot. , vol.34 , pp. 436-442
    • Kawaharajo, K.1    Sekizawa, Y.2    Inoue, M.3
  • 192
    • 0019837289 scopus 로고
    • Metabolism of 9,3-diacetyl midecamycin. II. The structures of several metabolites of 9,3-diacetyl midecamycin
    • Shomura T., Someya S., Murata S., Umemara K., Nishio M. Metabolism of 9,3-diacetyl midecamycin. II. The structures of several metabolites of 9,3-diacetyl midecamycin. Chem. Pharm. Bull. 1981, 29:2413-2419.
    • (1981) Chem. Pharm. Bull. , vol.29 , pp. 2413-2419
    • Shomura, T.1    Someya, S.2    Murata, S.3    Umemara, K.4    Nishio, M.5
  • 193
    • 84998353217 scopus 로고
    • A convenient method for the preparation of the acylated macrolide antibiotic midecamycin using molecular sieves and acylchloride
    • Nakamura T., Fukatsu S., Seki S., Niida T. A convenient method for the preparation of the acylated macrolide antibiotic midecamycin using molecular sieves and acylchloride. Chem. Lett. 1978, 1293-1296.
    • (1978) Chem. Lett. , vol.1293-1296
    • Nakamura, T.1    Fukatsu, S.2    Seki, S.3    Niida, T.4
  • 194
    • 0019295797 scopus 로고
    • Modification of macrolide antibiotic midecamycin. II. Reaction of midecamycin and 9-acetyl midecamycin with dimethylsulfoxide and acetic anhydride
    • Inoue S., Omoto S., Iwamatsu K., Niida T. Modification of macrolide antibiotic midecamycin. II. Reaction of midecamycin and 9-acetyl midecamycin with dimethylsulfoxide and acetic anhydride. J. Anibiot. 1980, 33:61-71.
    • (1980) J. Anibiot. , vol.33 , pp. 61-71
    • Inoue, S.1    Omoto, S.2    Iwamatsu, K.3    Niida, T.4
  • 196
    • 0019819389 scopus 로고
    • Acyl derivatives of 16-membered macrolides. II. Antibacterial activities and serum levels of 3-O-acyl deviratives of leucomycin
    • Sakakibara H., Okekawa O., Fujiwara T., Aizawa M., Omura S. Acyl derivatives of 16-membered macrolides. II. Antibacterial activities and serum levels of 3-O-acyl deviratives of leucomycin. J. Antibiot. 1981, 34:1011-1018.
    • (1981) J. Antibiot. , vol.34 , pp. 1011-1018
    • Sakakibara, H.1    Okekawa, O.2    Fujiwara, T.3    Aizawa, M.4    Omura, S.5
  • 198
    • 0021240289 scopus 로고
    • Chemical modification of spiramycins. III. Synthesis and antimicrobial activity of 4-sulfonates and 4-alkylethers of spiramycin I
    • Sano H., Sunazuka T., Tanaka H., Yamashita K., Okachi R., Omura S. Chemical modification of spiramycins. III. Synthesis and antimicrobial activity of 4-sulfonates and 4-alkylethers of spiramycin I. J. Antibiot. 1984, 37:750-759.
    • (1984) J. Antibiot. , vol.37 , pp. 750-759
    • Sano, H.1    Sunazuka, T.2    Tanaka, H.3    Yamashita, K.4    Okachi, R.5    Omura, S.6
  • 199
    • 0020836136 scopus 로고
    • Chemical modification of spiramycin. I. Synthesis of the acetal derivatives of neospiramycin I
    • Sano H., Inoue M., Yamashita K., Okachi R., Omura S. Chemical modification of spiramycin. I. Synthesis of the acetal derivatives of neospiramycin I. J. Antibiot. 1983, 36:1336-1344.
    • (1983) J. Antibiot. , vol.36 , pp. 1336-1344
    • Sano, H.1    Inoue, M.2    Yamashita, K.3    Okachi, R.4    Omura, S.5
  • 200
    • 85184381334 scopus 로고
    • Chemical modification of spiramycin. V. Synthesis and antimicrobial activity of 3' or 4-de-N-methylspiramycin I and 12 (Z)-isomers
    • Sano H., Tanaka H., Yamashita K., Okachi R., Omura S. Chemical modification of spiramycin. V. Synthesis and antimicrobial activity of 3' or 4-de-N-methylspiramycin I and 12 (Z)-isomers. J. Antibiot. 1984, 38:738-749.
    • (1984) J. Antibiot. , vol.38 , pp. 738-749
    • Sano, H.1    Tanaka, H.2    Yamashita, K.3    Okachi, R.4    Omura, S.5
  • 201
    • 0021242726 scopus 로고
    • Chemical modification of spiramycin. IV. Synthesis and in vitro and in vivo activities of 3, 4-diacylates and 3,3, 4-triacylates of spiramycin I
    • Sano H., Sunazuka T., Tanaka H., Yamashita K., Okachi R., Omura S. Chemical modification of spiramycin. IV. Synthesis and in vitro and in vivo activities of 3, 4-diacylates and 3,3, 4-triacylates of spiramycin I. J. Antibiot. 1984, 37:766-772.
    • (1984) J. Antibiot. , vol.37 , pp. 766-772
    • Sano, H.1    Sunazuka, T.2    Tanaka, H.3    Yamashita, K.4    Okachi, R.5    Omura, S.6
  • 202
    • 0022388597 scopus 로고
    • Structure-activity relationships of spiramycins
    • Omura S., Sano H., Sunazuka T. Structure-activity relationships of spiramycins. J. Antimicrob. Chemother. 1984, 16(Suppl. A):1-11.
    • (1984) J. Antimicrob. Chemother. , vol.16 , Issue.SUPPL A , pp. 1-11
    • Omura, S.1    Sano, H.2    Sunazuka, T.3
  • 203
    • 0017581717 scopus 로고
    • Evidence for configurational identity between leucomycin and tylosin
    • Omura S., Nakagawa A., Machida M., Imai H. Evidence for configurational identity between leucomycin and tylosin. Tethahedron Lett. 1977, 1045-1048.
    • (1977) Tethahedron Lett. , pp. 1045-1048
    • Omura, S.1    Nakagawa, A.2    Machida, M.3    Imai, H.4
  • 204
    • 0017643523 scopus 로고
    • High pressure liquid chromatography of the macrolide antibiotic tylosin
    • Bhuwapathanapun S., Gray P. High pressure liquid chromatography of the macrolide antibiotic tylosin. J. Antibiot. 1977, 30:673-674.
    • (1977) J. Antibiot. , vol.30 , pp. 673-674
    • Bhuwapathanapun, S.1    Gray, P.2
  • 208
    • 0021081122 scopus 로고
    • Chemical modification of tylosin: Synthesis of amino derivatives at C-20 position of tylosin and demycarosyl tylosin
    • Matsubara H., Inokoshi J., Nakagawa A., Tanaka H., Omura S. Chemical modification of tylosin: Synthesis of amino derivatives at C-20 position of tylosin and demycarosyl tylosin. J. Antibiot. 1983, 36:1713-1721.
    • (1983) J. Antibiot. , vol.36 , pp. 1713-1721
    • Matsubara, H.1    Inokoshi, J.2    Nakagawa, A.3    Tanaka, H.4    Omura, S.5
  • 209
    • 0020051943 scopus 로고
    • Novel dimeric derivatives of leucomycin and tylosin, sixteen-membered macrolides
    • Omura S., Miyano K., Matsubara H., Nakagawa A. Novel dimeric derivatives of leucomycin and tylosin, sixteen-membered macrolides. J. Med. Chem. 1982, 25:271-275.
    • (1982) J. Med. Chem. , vol.25 , pp. 271-275
    • Omura, S.1    Miyano, K.2    Matsubara, H.3    Nakagawa, A.4
  • 211
  • 212
    • 0024385984 scopus 로고
    • Synthesis and antibacterial activity of 9-O-((2-methoxyethoxy)methyl)-oxime of tylosin and desmycarosyl tylosin
    • Ruggeri C., Laborde M.L.A., Dessinges A., Ming L., Olesker A., Lukacs G. Synthesis and antibacterial activity of 9-O-((2-methoxyethoxy)methyl)-oxime of tylosin and desmycarosyl tylosin. J. Antibiot. 1989, 42:1442-1445.
    • (1989) J. Antibiot. , vol.42 , pp. 1442-1445
    • Ruggeri, C.1    Laborde, M.L.A.2    Dessinges, A.3    Ming, L.4    Olesker, A.5    Lukacs, G.6
  • 213
    • 0019177994 scopus 로고
    • Mycamicins, new macrolide antibiotics. I. Taxonomy, production, isolation, characterization and properties
    • Satoi S., Muto N., Hayashi M., Fujii T., Otani M. Mycamicins, new macrolide antibiotics. I. Taxonomy, production, isolation, characterization and properties. J. Antibiot. 1980, 33:364-376.
    • (1980) J. Antibiot. , vol.33 , pp. 364-376
    • Satoi, S.1    Muto, N.2    Hayashi, M.3    Fujii, T.4    Otani, M.5
  • 214
    • 0024405240 scopus 로고
    • 19-Deformyl-4'-deoxydesmycosin (TMC-016): Synthesis and biological properties of a unique 16-membered macrolide antibiotic
    • Fujiwara T., Watanabe H., Kogami Y., Shiritani Y., Sakakibara H. 19-Deformyl-4'-deoxydesmycosin (TMC-016): Synthesis and biological properties of a unique 16-membered macrolide antibiotic. J. Antibiot. 1989, 42:903-912.
    • (1989) J. Antibiot. , vol.42 , pp. 903-912
    • Fujiwara, T.1    Watanabe, H.2    Kogami, Y.3    Shiritani, Y.4    Sakakibara, H.5
  • 216
    • 85184355542 scopus 로고
    • Synthesis and antimicrobial activities of 9-N, N-dialkylamino-9-deoxo-10, 11, 12, 13-tetrahydroniddamycins
    • Presented at 29th Intersci. Conf. Antimicrob. Agents Chemother
    • Freiberg L.A., Maring C.J., Lartey P.A., Edwards D., Grampovnick D., Hardy D., Fernandes P.B. Synthesis and antimicrobial activities of 9-N, N-dialkylamino-9-deoxo-10, 11, 12, 13-tetrahydroniddamycins. Astr. No. 1032. 1989.
    • (1989) Astr. No. 1032.
    • Freiberg, L.A.1    Maring, C.J.2    Lartey, P.A.3    Edwards, D.4    Grampovnick, D.5    Hardy, D.6    Fernandes, P.B.7
  • 217
    • 85184386112 scopus 로고
    • Synthesis and SAR of 9(R)-N, N-dialkylamino-9-deoxoderivatives of 16-membered macrolides
    • Presented at 30th Intersci. Conf. Antimicrob. Agents Chemother
    • Maring C.J., Grampovnick D., Bacino D., Lartey P.A., Hardy D., Clement J. Synthesis and SAR of 9(R)-N, N-dialkylamino-9-deoxoderivatives of 16-membered macrolides. Abstr. No. 812 1990.
    • (1990) Abstr. No. 812
    • Maring, C.J.1    Grampovnick, D.2    Bacino, D.3    Lartey, P.A.4    Hardy, D.5    Clement, J.6
  • 218
    • 37049073133 scopus 로고
    • Semisynthetic macrolide antibacterials derived tylosin. Synthesis of 23-O-demycinosyl tylosin and related compounds
    • Mallams A.K., Rossman R.R. Semisynthetic macrolide antibacterials derived tylosin. Synthesis of 23-O-demycinosyl tylosin and related compounds. J. Chem. Soc. Perkin Trans. 1989, 1:775-785.
    • (1989) J. Chem. Soc. Perkin Trans. , vol.1 , pp. 775-785
    • Mallams, A.K.1    Rossman, R.R.2
  • 222
    • 0024450271 scopus 로고
    • The status of ivermectin in the treatment of onchocerciasis
    • Taylor H.R., Greene B.M. The status of ivermectin in the treatment of onchocerciasis. Am. J. Trop. Hyg. 1989, 41:460-466.
    • (1989) Am. J. Trop. Hyg. , vol.41 , pp. 460-466
    • Taylor, H.R.1    Greene, B.M.2
  • 226
    • 0026024283 scopus 로고
    • Branched chain acid requirement for avermectin produced by a mutant of Streptomyces avermitilis lacking branched-chain 2-oxo acid dehydrogenase activity
    • Hafner E.W., Holley B.W., Holdom K.S., Lee S.E., Wox R.G., Bech D., McArthur H.A.I., Wernau W.C. Branched chain acid requirement for avermectin produced by a mutant of Streptomyces avermitilis lacking branched-chain 2-oxo acid dehydrogenase activity. J. Antibiot. 1991, 44:349-356.
    • (1991) J. Antibiot. , vol.44 , pp. 349-356
    • Hafner, E.W.1    Holley, B.W.2    Holdom, K.S.3    Lee, S.E.4    Wox, R.G.5    Bech, D.6    McArthur, H.A.I.7    Wernau, W.C.8
  • 238
    • 0019216927 scopus 로고
    • A new family of macrolide antibiotics: Fermentation, isolation and physico-chemical properties
    • Takiguchi Y., Mishima H., Okuda M., Terao M., Aoki A., Fukada R. A new family of macrolide antibiotics: Fermentation, isolation and physico-chemical properties. J. Antibiot. 1980, 33:1120-1127.
    • (1980) J. Antibiot. , vol.33 , pp. 1120-1127
    • Takiguchi, Y.1    Mishima, H.2    Okuda, M.3    Terao, M.4    Aoki, A.5    Fukada, R.6
  • 239
    • 0020607636 scopus 로고
    • Milbemycins, a new family of macrolide antibiotics: Structure determination of milbemycin, D, E, F, G, H, I, J and K
    • Mishima H., Ide J., Muramatsu S., Ono M. Milbemycins, a new family of macrolide antibiotics: Structure determination of milbemycin, D, E, F, G, H, I, J and K. J. Antibiot. 1983, 36:980-990.
    • (1983) J. Antibiot. , vol.36 , pp. 980-990
    • Mishima, H.1    Ide, J.2    Muramatsu, S.3    Ono, M.4
  • 240
    • 0023886117 scopus 로고
    • LL-F28249 antibiotics complex: A new family of antiparasitic macrocyclic lactones. Isolation, characterization, and structures of LL-F28249 α, β, γ, λ
    • Carter G.T., Nietsche J.A., Hertz M.R., Williams D.R., Siegel M.M., Morton G.O., James J.C., Border D.B. LL-F28249 antibiotics complex: A new family of antiparasitic macrocyclic lactones. Isolation, characterization, and structures of LL-F28249 α, β, γ, λ. J. Antibiot. 1988, 41:519-529.
    • (1988) J. Antibiot. , vol.41 , pp. 519-529
    • Carter, G.T.1    Nietsche, J.A.2    Hertz, M.R.3    Williams, D.R.4    Siegel, M.M.5    Morton, G.O.6    James, J.C.7    Border, D.B.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.